Page 9 - Commons Project News Today

With widespread overseas travel unlikely until at least 2022, could we be on the brink of a document that’ll make international jaunts come back sooner?

They are being spruiked as the post-pandemic ticket to travel freedom. A ‘passport’ of sorts which will play as a crucial key for cities and countries reliant on tourism dollars to revive struggling economies. Dubbed the ‘vaccine pass’ or ‘vaccine passport’, these documents – which are going to be trialled by Air New Zealand from April on flights between Auckland and Sydney – would essentially be a digital document than ensures tourists are virus-free whe...

The coronavirus pandemic is still extremely serious. Families are grieving: more than 108,000 people have died from Covid-19 in the UK. The virus spread rapidly across the world and into the UK by air travel. And the UK lockdown means holidays at home or abroad are currently illegal. But many people are looking ahead to later in 2021 and the opportunities for future holidays. With the UK well ahead of other major European nations in its...

Immunotourism: How Covid vaccines could open up your holiday plans Simon Calder © Provided by The Independent The coronavirus pandemic is still extremely serious. Families are grieving: more than 108,000 people have died from Covid-19 in the UK. The virus spread rapidly across the world and into the UK by air travel. And the UK lockdown means holidays at home or abroad are currently illegal. But many people are looking ahead to later in 2021 and the opportunities for future ho...

Press release content from Business Wire. The AP news staff was not involved in its creation. Indapta Therapeutics Announces Key Management Team Appointments to Advance into Clinical Trials in 2021 February 3, 2021 GMT SAN FRANCISCO--(BUSINESS WIRE)--Feb 3, 2021-- Indapta Therapeutics Inc. (“Indapta”), a biotechnology company focused on developing and commercializing a proprietary, first-in-class, off-the-shelf, non-engineered, allogeneic FcRγ-deficient natural killer (G-NK) cell therapy t...

Clara Ferreira Marques: Traveler quarantines aren’t going away soon Summary: Passes in some form will eventually help open up economies and travel, and limit the bane of lockdowns and quarantines. Vaccines may be the practical proxy, even if immunity would be ideal, as would a standardized, global approach. But we need to have far more answers to avoid creating a false sense of security and unintended consequences. Written By: Clara Ferreira Marques | 8:00 am, Jan. 29, 202...

A One of US President Joe Biden’s first moves upon arriving in the Oval Office has been to require international travelers get a negative Covid-19 test before departing, then quarantine on landing; Britain too is considering tighter measures for arrivals. Both basic protective moves are long overdue. They are also an acknowledgement that carefree trips are still many months away. In part, that’s because the virus is still advancing fast — aided by a new, more transmissible and poten...

The first confirmed case of SARS-CoV-2 infection in the United States was reported one year ago today. A year later, 24 million Americans have been infected and 400,000 have died (worldwide, the sums are 95 million and two million, respectively). This pandemic doesn’t give a damn about partisan politics, presidential or otherwise. It methodically, cruelly rolls on as vaccines slowly, tentatively roll out—and as one administration rolls into another. The new President has promised a herc...

January 17, 2021 | The Year Ahead – Part 2: Biosecurity James Corbett The Corbett Report is an independent, listener-supported alternative news source. It operates on the principle of open source intelligence and provides podcasts, interviews, articles and videos about breaking news and important issues from 9/11 Truth and false flag terror to the Big Brother police state, eugenics, geopolitics, the central banking fraud and more. I don’t need to tell you that we are living through world-h...

A variety of new smartphone apps are being developed to help Americans navigate the COVID-19 pandemic.